Sperling Prostate Center

Tag: MRI

Can PET/MRI for Breast Cancer Show the Way to Eliminate Prostate Biopsies?

Pet Scan Technique Provides Best Prostate Cancer Metastasis Information - Sperling Prostate Center
Advances in medicine sometimes involve hybrid technologies, often with stunning results. Just as hybrid cars produce vehicles that offer the best of two worlds in one, integrating two different medical imaging technologies can accomplish the same goal. PET and MRI scans Combining Positron Emitting Tomography (PET) scanning with Magnetic Resonance Imaging (MRI) boosts the accuracy keep reading

Artificial Intelligence in Medicine: Dr. Sperling’s Early Contributions to AI in Imaging

Artificial Intelligence and Radiology - Sperling Prostate Center
Considering ever-developing advances in computational power and availability of large data sets, the marriage of humans and machines in future clinical practice seems inevitable. Therefore, regardless of their feelings, the radiologists should be familiar with these concepts.[i] A seemingly unquenchable thirst for efficient, highly accurate and patient-friendly imaging drives the ongoing integration of Artificial Intelligence keep reading

Artificial Intelligence in Medicine: Will Artificial Intelligence Put Radiologists Out of Business?

Will Artificial Intelligence Put Radiologists Out of Business? - Sperling Prostate Center
AI applications are entering clinics at a rapid rate, and physicians have met the technology with equal parts excitement about its potential to reduce their workload and fear about losing their jobs to machines.[i]   Who’s afraid of the big bad computer? Apparently, some radiologists—and even medical students contemplating entering that field—are fearful of being keep reading

Why Fusion-Guided Biopsies Should Not Be Called “MRI-Guided Biopsies”

Proton Beam Therapy - Sperling Prostate Center
Fusion guided prostate biopsies are the new darling of urologic diagnostic procedures. For decades, the transrectal ultrasound (TRUS) guided 12-plus needle sampling of the gland was the prostate cancer (PCa) diagnostic gold standard, despite its widely recognized shortcoming: Inaccuracy rates of at least 30% on average Overdetecting insignificant PCa while often missing significant PCa Tends keep reading
WordPress Image Lightbox